Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

ABSTRACT:

SUBMITTER: Paul B 

PROVIDER: S-EPMC12143418 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature